Skip to main content

David Rodriguez Luna

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

David Rodriguez Luna

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

Impact of time to achieve blood pressure control on hematoma expansion in patients with acute intracerebral hemorrhage

IP: David Rodriguez Luna
Collaborators: Maria Mar Hernandez Guillamon, Mª Ángeles Muchada López
Funding agency: Fundació La Marató de TV3
Funding: 177052.88
Reference: 20173030
Duration: 01/01/2018 - 31/01/2022

ITACAT: Impact of Thrombus Analysis in stroke patients in CATalonia.

IP: Carlos Molina Cateriano
Collaborators: Santiago Ramon y Cajal Agüeras, Jorge Pagola Pérez Blanca, Carlos Palacio García, Noelia Rodríguez Villatoro, David Rodriguez Luna
Funding agency: Fundació La Marató de TV3
Funding: 197973.69
Reference: 20171930
Duration: 01/01/2018 - 31/01/2022

Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial

IP: Carlos Molina Cateriano
Collaborators: Marta Aurora Rubiera Del Fueyo, David Rodriguez Luna, Mª Ángeles Muchada López
Funding agency: National Health and Medical Res Council (NHMR
Funding: 1950
Reference: TASTE_HMRI2012101
Duration: 19/04/2017 - 16/04/2018

Malalties Neurovasculars (GRC)

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Malalties Neurovasculars (GRC), José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Malalties Neurovasculars (GRC), Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 48000
Reference: 2014 SGR 686
Duration: 01/01/2014 - 31/12/2016

Related news

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

The award is a recognition for his significant contribution to the development of research in multiple sclerosis within the Catalan Institute of Health.

Related professionals

Josep Majo Llopart

Josep Majo Llopart

Predoctoral researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Tatiana Murillo Fontana

Tatiana Murillo Fontana

Read more
Clara Serra Juhe

Clara Serra Juhe

Postdoctoral researcher
Genetics Medicine
Read more
Jose Alemañ Diez

Jose Alemañ Diez

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.